DNA analyzing firm 23andMe confirmed a massive data breach, which affects over six million users. DNA analyzing firm 23andMe confirmed a massive data breach that exposed the information of millions of its users.
DNA analyzing firm 23andMe confirmed a massive data breach, which affects over six million users. DNA analyzing firm 23andMe confirmed a massive data breach that exposed the information of millions of its users.
The UK's MHRA approved Casgevy, the first gene therapy treatment for sickle cell disease. The United Kingdom's Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy, the first gene therapy treatment for sickle cell disease.
This AI-powered tool promises the large-scale development of gene editing. A new artificial intelligence program may just be the driving force behind the first simple production of modifiable proteins called zinc fingers that would treat diseases by switching genes on and off.